Primary neuroendocrine carcinoma of the breast

Breast J. 2019 May;25(3):519-520. doi: 10.1111/tbj.13260. Epub 2019 Apr 18.

Authors

Colin Bergstrom¹, Jessica Porembka², Yisheng Fang³, Venetia Sarode³, Samira Syed⁴

Affiliations

¹ University of Texas Southwestern Department of Internal Medicine, Dallas, Texas.
² University of Texas Southwestern Medical Center at Dallas, Radiology, Dallas, Texas.
³ Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
⁴ Hematology/Oncology Department of Internal Medicine University of Texas Southwestern Medical Center, Dallas, Texas.

PMID: 31001910
DOI: 10.1111/tbj.13260

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms / diagnostic imaging*
Breast Neoplasms / drug therapy
Breast Neoplasms / metabolism
Breast Neoplasms / pathology*
Carcinoma, Neuroendocrine / diagnostic imaging*
Carcinoma, Neuroendocrine / drug therapy
Carcinoma, Neuroendocrine / metabolism
Carcinoma, Neuroendocrine / pathology*
Cisplatin / administration & dosage
Contrast Media
Etoposide / administration & dosage
Female
Humans
Magnetic Resonance Imaging / methods
Middle Aged
Receptors, Estrogen / metabolism
Receptors, Progesterone / metabolism
Ultrasonography, Mammary

Substances

Contrast Media
Receptors, Estrogen
Receptors, Progesterone
Etoposide
Cisplatin